Canadian tech brand NuraLogix introduced the Anura MagicMirror at CES 2024, showcasing an AI mirror capable of assessing health risks from a brief 30-second pose.
The Anura MagicMirror analyzes blood flow and extracts information from key facial regions. NuraLogix utilizes its patented Transdermal Optical Imaging (TO) technology, a unique form of Remote Photoplethysmography (rPPG), to automatically detect and analyze a person’s face. The gathered data is then transmitted to the cloud-based DeepAffex platform, employing advanced signal processing and machine learning AI algorithms to calculate over 100 health parameters.
Notably, the MagicMirror predicts disease risks, providing a percentage likelihood of heart disease, stroke, type-2 diabetes, and fatty liver disease. The mirror generates an overall wellness score of 100, with users receiving a colorful representation of their health parameters in red, yellow, and green. A healthy individual will see all results in the green region.
Despite its potential for personal health monitoring, the MagicMirror is not intended for home use. NuraLogix suggests it may find a place in kiosks, pharmacies, doctor’s offices, or health hubs. While consumer pricing information is not yet available, NuraLogix mentions the possibility of selling the software individually.
The Anura MagicMirror represents a significant advancement in AI technology for health assessment, offering a glimpse into the future of personalized health monitoring.
 technology, a unique form of Remote Photoplethysmography (rPPG), to […]&media=https://wonderfulengineering.com/wp-content/uploads/2024/01/image-295.png){kind=link}